143 related articles for article (PubMed ID: 12796021)
1. Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
Xenidis N; Vlachonikolis I; Mavroudis D; Perraki M; Stathopoulou A; Malamos N; Kouroussis C; Kakolyris S; Apostolaki S; Vardakis N; Lianidou E; Georgoulias V
Ann Oncol; 2003 Jun; 14(6):849-55. PubMed ID: 12796021
[TBL] [Abstract][Full Text] [Related]
2. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
J Clin Oncol; 2002 Aug; 20(16):3404-12. PubMed ID: 12177100
[TBL] [Abstract][Full Text] [Related]
3. Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance.
Apostolaki S; Perraki M; Pallis A; Bozionelou V; Agelaki S; Kanellou P; Kotsakis A; Politaki E; Kalbakis K; Kalykaki A; Vamvakas L; Georgoulias V; Mavroudis D
Ann Oncol; 2007 May; 18(5):851-8. PubMed ID: 17301075
[TBL] [Abstract][Full Text] [Related]
4. Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes.
Stathopoulos EN; Sanidas E; Kafousi M; Mavroudis D; Askoxylakis J; Bozionelou V; Perraki M; Tsiftsis D; Georgoulias V
Ann Oncol; 2005 Feb; 16(2):240-6. PubMed ID: 15668277
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Xenidis N; Ignatiadis M; Apostolaki S; Perraki M; Kalbakis K; Agelaki S; Stathopoulos EN; Chlouverakis G; Lianidou E; Kakolyris S; Georgoulias V; Mavroudis D
J Clin Oncol; 2009 May; 27(13):2177-84. PubMed ID: 19332733
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of the primary tumor have independent prognostic value in early breast cancer.
Tryfonidis K; Kafousi M; Perraki M; Apostolaki S; Agelaki S; Georgoulias V; Stathopoulos E; Mavroudis D
Clin Breast Cancer; 2014 Dec; 14(6):442-50. PubMed ID: 24958324
[TBL] [Abstract][Full Text] [Related]
7. Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
Bozionellou V; Mavroudis D; Perraki M; Papadopoulos S; Apostolaki S; Stathopoulos E; Stathopoulou A; Lianidou E; Georgoulias V
Clin Cancer Res; 2004 Dec; 10(24):8185-94. PubMed ID: 15623593
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer-specific mRNA transcripts presence in peripheral blood after adjuvant chemotherapy predicts poor survival among high-risk breast cancer patients treated with high-dose chemotherapy with peripheral blood stem cell support.
Quintela-Fandino M; López JM; Hitt R; Gamarra S; Jimeno A; Ayala R; Hornedo J; Guzman C; Gilsanz F; Cortés-Funes H
J Clin Oncol; 2006 Aug; 24(22):3611-8. PubMed ID: 16877728
[TBL] [Abstract][Full Text] [Related]
9. Molecular detection and prognostic value of circulating cytokeratin-19 messenger RNA-positive and HER2 messenger RNA-positive cells in the peripheral blood of women with early-stage breast cancer.
Ignatiadis M; Perraki M; Apostolaki S; Politaki E; Xenidis N; Kafousi M; Stathopoulos E; Lianidou E; Sotiriou C; Georgoulias V; Mavroudis D
Clin Breast Cancer; 2007 Dec; 7(11):883-9. PubMed ID: 18269779
[TBL] [Abstract][Full Text] [Related]
10. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.
Lin JC; Chen KY; Wang WY; Jan JS; Liang WM; Wei YH
Int J Cancer; 2002 Feb; 97(4):548-53. PubMed ID: 11802221
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.
Saloustros E; Perraki M; Apostolaki S; Kallergi G; Xyrafas A; Kalbakis K; Agelaki S; Kalykaki A; Georgoulias V; Mavroudis D
Breast Cancer Res; 2011 Jun; 13(3):R60. PubMed ID: 21663668
[TBL] [Abstract][Full Text] [Related]
13. Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
Ntoulia M; Stathopoulou A; Ignatiadis M; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
Clin Biochem; 2006 Sep; 39(9):879-87. PubMed ID: 16925986
[TBL] [Abstract][Full Text] [Related]
14. Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients.
Xenidis N; Perraki M; Kafousi M; Apostolaki S; Bolonaki I; Stathopoulou A; Kalbakis K; Androulakis N; Kouroussis C; Pallis T; Christophylakis C; Argyraki K; Lianidou ES; Stathopoulos S; Georgoulias V; Mavroudis D
J Clin Oncol; 2006 Aug; 24(23):3756-62. PubMed ID: 16769987
[TBL] [Abstract][Full Text] [Related]
15. Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes.
Shapiro CL; Gelman RS; Hayes DF; Osteen R; Obando A; Canellos GP; Frei E; Henderson IC
J Natl Cancer Inst; 1993 May; 85(10):812-7. PubMed ID: 8487326
[TBL] [Abstract][Full Text] [Related]
16. Serum IGF-1, IGFBP-3 levels and circulating tumor cells (CTCs) in early breast cancer patients.
Papadakis GZ; Mavroudis D; Georgoulias V; Souglakos J; Alegakis AK; Samonis G; Bagci U; Makrigiannakis A; Zoras O
Growth Horm IGF Res; 2017 Apr; 33():28-34. PubMed ID: 28258988
[TBL] [Abstract][Full Text] [Related]
17. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
[TBL] [Abstract][Full Text] [Related]
18. Molecular detection of disseminated tumor cells in the peripheral blood of patients with gastric cancer: evaluation of their prognostic significance.
Wu CH; Lin SR; Hsieh JS; Chen FM; Lu CY; Yu FJ; Cheng TL; Huang TJ; Huang SY; Wang JY
Dis Markers; 2006; 22(3):103-9. PubMed ID: 16788243
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of circulating CK-19 mRNA-positive cells detected during the adjuvant tamoxifen treatment in patients with early breast cancer.
Xenidis N; Markos V; Apostolaki S; Perraki M; Pallis A; Sfakiotaki G; Papadatos-Pastos D; Kalmanti L; Kafousi M; Stathopoulos E; Kakolyris S; Mavroudis D; Georgoulias V
Ann Oncol; 2007 Oct; 18(10):1623-31. PubMed ID: 17515404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
